SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

Core Insights - SINTX Technologies, Inc. has appointed Gregg R. Honigblum as Chief Strategy Officer to lead corporate strategy and growth initiatives [2][5] - Honigblum has over 35 years of experience in the healthcare sector, including investment banking and executive roles in emerging growth companies [3][4] - His previous successes include raising over $500 million for various ventures and being instrumental in early-stage investments in notable companies like Myriad Genetics and Acacia Biosciences [4] Company Overview - SINTX Technologies specializes in advanced ceramics for medical and technical applications, particularly in the development and commercialization of silicon nitride [6] - The company has been a leader in research, development, and manufacturing since 2008, with facilities in Utah and Maryland [6] - SINTX has utilized strategic acquisitions and alliances to expand into new markets [6]